Page last updated: 2024-10-30

lorazepam and Cortical Lewy Body Disease

lorazepam has been researched along with Cortical Lewy Body Disease in 1 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Research Excerpts

ExcerptRelevanceReference
"A 76-year-old woman presented with catatonia, refusal to eat due to delusion, and visual hallucination."5.37Amitriptyline and lorazepam improved catatonia and occipital hypoperfusion in a patient with DLB. ( Maeda, K; Ogawa, N, 2011)
"A 76-year-old woman presented with catatonia, refusal to eat due to delusion, and visual hallucination."1.37Amitriptyline and lorazepam improved catatonia and occipital hypoperfusion in a patient with DLB. ( Maeda, K; Ogawa, N, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maeda, K1
Ogawa, N1

Other Studies

1 other study available for lorazepam and Cortical Lewy Body Disease

ArticleYear
Amitriptyline and lorazepam improved catatonia and occipital hypoperfusion in a patient with DLB.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:4

    Topics: Aged; Amitriptyline; Catatonia; Cerebrovascular Circulation; Female; Humans; Iofetamine; Lewy Body D

2011